UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported):
May 6, 2015

 

USANA HEALTH SCIENCES, INC.

(Exact name of registrant as specified in its charter)

 

Utah

(State or other jurisdiction of incorporation)

 

001-35024

 

87-0500306

(Commission File No.)

 

(IRS Employer Identification

 

 

Number)

 

3838 West Parkway Boulevard
Salt Lake City, Utah 84120

(Address of principal executive offices, Zip Code)

 

Registrant’s telephone number, including area code: (801) 954-7100

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 5.07                                           Submission of Matters to a Vote of Security Holders.

 

The Company held its Annual Meeting of Shareholders on May 6, 2015.  A total of 11,684,325 shares (approximately 92%) of the issued and outstanding shares of USANA common stock were represented by proxy or in person at the meeting.  The following matters were submitted and voted upon at the Annual Meeting:

 

1.              USANA shareholders voted to elect five individuals to the Board of Directors for the succeeding year as set forth below:

 

 

 

 

 

Number of

 

Number of

 

 

 

 

 

Number of

 

Shares

 

Shares

 

Broker Non-

 

Name

 

Shares For

 

Withheld

 

Abstaining

 

Votes

 

 

 

 

 

 

 

 

 

 

 

Myron W. Wentz, PhD

 

10,928,959

 

105,545

 

 

649,821

 

Ronald S. Poelman

 

9,669,463

 

1,365,041

 

 

649,821

 

Robert Anciaux

 

10,971,616

 

62,888

 

 

649,821

 

Jerry G. McClain

 

10,941,790

 

92,714

 

 

649,821

 

Gilbert A. Fuller

 

10,885,530

 

148,974

 

 

649,821

 

 

2.              USANA shareholders voted to approve the company’s 2015 Equity Incentive Award Plan as set forth below:

 

 

 

Number of

 

Number of

 

 

 

Number of

 

Shares

 

Shares

 

Broker Non-

 

Shares For

 

Withheld

 

Abstaining

 

Votes

 

7,433,453

 

3,596,793

 

4,258

 

649,821

 

 

3.              USANA shareholders voted to ratify the Board’s selection of KPMG LLP as our independent registered public accounting firm for fiscal year 2015 as set forth below:

 

 

 

Number of

 

Number of

 

 

 

Number of

 

Shares

 

Shares

 

Broker Non-

 

Shares For

 

Withheld

 

Abstaining

 

Votes

 

11,675,912

 

1,959

 

6,454

 

 

 

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

USANA HEALTH SCIENCES, INC.

 

 

 

 

 

By:

/s/ Paul A. Jones

 

 

 

Paul A. Jones, Chief Financial Officer

 

Date:  May 8, 2015

 

3